Delta 9 Cannabis Inc., a Canadian cannabis company, is currently facing significant financial challenges despite its ongoing efforts to expand its retail operations.

The company's market capitalization is currently valued at just €3.3 million, with shares priced at €0.007, indicating that the company is undervalued. The price-to-sales ratio is exceptionally low at 0.00, suggesting potential growth opportunities for investors.

In a surprising move, Delta 9 Cannabis has announced plans to pay a dividend of €34.00 per share for the 2024 financial year, which would result in a remarkable yield of 485,714.29%. However, considering the company's precarious financial situation, shareholders should carefully examine this dividend declaration.

Recent analyses emphasize the need for action among Delta 9 Cannabis shareholders, leading to discussions on whether to invest or divest. It is important for investors to stay informed as the situation develops, with further information available in the latest financial assessments.